QTI

Agreement provides access to 4,400 U.S. hospitals and health systems and provides Premier members pre-negotiated pricing and terms QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its U.S. distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., has entered into a national group purchasing agreement with Premier, Inc. covering the QTI Breast Acoustic CT™ scanner and providing access to nearly 4,400 hospitals and health systems nationwide. The agreement allows eligible P

Code 1079T is effective as of October 1, 2026, three months earlier than anticipated QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that CPT® Category III code 1079T for 3D quantitative transmission water bath volumetric ultrasound tomography of the breast is effective for dates of service beginning October 1, 2026. The code is effective for use three months earlier than the Company had previously anticipated. The earlier effective date allows healthcare providers to begin using a dedicated CPT code to report this bre

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that Chief Executive Officer Dr. Raluca Dinu will ring the Nasdaq Stock Market Closing Bell on October 2, 2026, in recognition of Breast Cancer Awareness Month. She will be joined by QT Imaging’s executive leadership, team members, and key partners. The ceremony will take place at Nasdaq MarketSite in New York City's Times Square and will highlight the importance of breast health, early detection, and continued innovation in breast imaging. "Ringing the Nasdaq Closing Bel

S-8 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

Recognition highlights the Company’s FDA-cleared Breast Acoustic CT™ Scanner and its innovative approach to breast imaging QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced it will be honored during Premier’s annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, taking place October 6-8, 2026. The Innovation Celebration recognizes groundbreaking healthcare technologies launched throughout the year and highlights how these products help improve the health of communities. Premier’s I

Co-founder and former president of Steinberg Diagnostic Medical Imaging brings decades of clinical and business leadership as QT Imaging advances commercialization QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Mark L. Winkler, M.D., as Chief Medical Officer (CMO). "Mark has the perspective of an accomplished radiologist along with the experience of an entrepreneur who has built and scaled a very successful imaging organization," said Dr. Raluca Dinu, QT Imaging’s Chief Executive Officer. "He unders

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its participation in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, taking place September 15–16, 2026. Chief Financial Officer Jay Jennings will deliver a company presentation at 3:30 pm ET on September 15, followed by one-on-one investor meetings on September 16. A live webcast of the presentation will be available at this link, and a replay will be accessible following the event. The presentation will also be available on the company’s website unde

RALEIGH, NC / ACCESS Newswire / September 8, 2026 / iAccess Alpha today announced that it will host its Virtual Best Ideas Fall Investment Conference on September 15-16, 2026, bringing together small and microcap public companies and investors for two days of company presentations and 1x1 meetings. The conference will begin on Tuesday, September 15, 2026, with a series of live-streamed company presentations. The second day, Wednesday, September 16, 2026, will be dedicated to 1x1 meetings between presenting companies and pre-qualified investors.How to AttendInvestors and industry professionals may register to view presentations and request 1x1 meetings by visiting the official event website:

4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

  QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today issued a mid-year 2026 letter to shareholders from its CEO, Dr. Raluca Dinu. The full text of the letter appears below and at this link which can be found on the QT Imaging website. Dear Fellow Shareholders, I am energized by QT Imaging’s many accomplishments so far in 2026, with impressive results by most any metric. Last week’s announcement of our second quarter financial results provides the catalyst for a review of the progress we’ve made, the foundation we’re building, and

10-Q - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

Second-quarter revenue reached $7.4 million; first-half revenue increased 116% to $14.0 million, with 28 scanners shipped Strengthened capital position through a $10.0 million public offering and expanded direct U.S. commercial capabilities to accelerate adoption Reaffirms full-year 2026 revenue guidance of approximately $39 million Conference Call begins at 4:30 p.m. Eastern Time today QT Imaging Holding, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and six months ended June 30, 2026, and provided a b

4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the second quarter ended June 30, 2026, after market close on Wednesday, August 12, 2026, and will host a conference call beginning at 4:30 p.m. Eastern Time. Participants are encouraged to pre-register at the link below. Date: Wednesday, August 12, 2026 Time: 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time Pre-registration: Link here. Callers who are unable to pre-register can access the conference call by dialing: United State

Appoints breast imaging industry veterans Jason Dyer as VP Regional Sales East and Dave Reinhart as VP Regional Sales West QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today advanced the direct U.S. commercial strategy for its Breast Acoustic CT™ Scanner with the appointment of Jason Dyer as Vice President Regional Sales East and Dave Reinhart as Vice President Regional Sales West. Both executives joined QT Imaging in July 2026 and report to Satrajit Misra, the Company’s Chief Commercial Officer. "Building a direct U.S. commercial

S-8 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

Dr. Albright brings more than 25 years of experience expanding markets and use cases across medical imaging, digital health, and oncology AI QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Julia Albright, Ph.D., as Chief Science Officer ("CSO"), effective July 27, 2026. Dr. Albright brings more than 25 years of experience spanning medical imaging, digital health, oncology, cloud technologies, and the development and commercialization of innovative healthcare technologies. As Chief Science Officer, sh

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

QT Imaging Holdings, Inc. ("QT Imaging" or the "Company") (NASDAQ:QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today that at the Annual Meeting of Company’s stockholders (the "Annual Meeting") held on July 28, 2026, the Company’s stockholders voted to approve (i) the election of Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the Company’s 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified, (ii) the appointment of BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December

Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports expansion of clinical research collaborations QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Israeli Ministry of Health has granted registration for the Company's scanner, authorizing commercialization of the system in Israel through February 2, 2028. The approval is based on the Company's existing U.S. FDA clearance and applicable Israeli regulatory requirements. QT Imaging’s Breast Acoustic CT™ Scanner produces t